Close
Close
Treatment Database
Recombinant human monoclonal IgG1 antibody for fibroblast growth factor 23
Trade Name CRYSVITA
Orphan Indication X-linked hypophosphataemia
EU Market Approval 21-02-2018
EU Designation Date 15-10-2014
Sponsor Kyowa Kirin Holdings B.V.
More about Alport syndrome
Free Newsletter
Related Videos
by Abidemi Uruejoma
5,590 views